Nuclear b-catenin is a transcriptional coactivator of LEF-1/TCF DNA-binding proteins in the Wnt/Wg signaling pathway [1] . Casein Kinase 2 (CK2), a positive regulator of Wnt signaling [2] [3] [4] , is present in b-catenin complexes [5, 6] and activated in Wnt-signaling cells [7] . We show here that CK2 enhances b-catenin: LEF-1 transactivation in vivo and in vitro and that bcatenin and CK2 cycle on and off the DNA in an alternating manner with the TLE1 corepressor at Wnt target genes. Interestingly, CK2 phosphorylates hLEF-1 directly and stimulates binding and transactivation of b-catenin:LEF-1 complexes on chromatin templates in vitro. In vitro, CK2 phosphorylation of hLEF-1 strongly enhances its affinity for b-catenin and reduces its affinity for TLE1. MALDI-TOF mass spectrometry (MS) identified two CK2 phosphorylation sites (S42, S61) within the amino terminus of hLEF-1, and mutation of these sites reduced binding to b-catenin in vitro and transactivation in vivo. Remarkably, treatment of cells with TBB, a pharmaceutical inhibitor of CK2, blocked the recruitment and cycling of b-catenin and TLE1 at Wnt target genes in vivo. Taken together, these data indicate that CK2 is required for the assembly and cycling of Wnt-enhancer complexes in vivo.
Summary
Nuclear b-catenin is a transcriptional coactivator of LEF-1/TCF DNA-binding proteins in the Wnt/Wg signaling pathway [1] . Casein Kinase 2 (CK2), a positive regulator of Wnt signaling [2] [3] [4] , is present in b-catenin complexes [5, 6] and activated in Wnt-signaling cells [7] . We show here that CK2 enhances b-catenin: LEF-1 transactivation in vivo and in vitro and that bcatenin and CK2 cycle on and off the DNA in an alternating manner with the TLE1 corepressor at Wnt target genes. Interestingly, CK2 phosphorylates hLEF-1 directly and stimulates binding and transactivation of b-catenin:LEF-1 complexes on chromatin templates in vitro. In vitro, CK2 phosphorylation of hLEF-1 strongly enhances its affinity for b-catenin and reduces its affinity for TLE1. MALDI-TOF mass spectrometry (MS) identified two CK2 phosphorylation sites (S42, S61) within the amino terminus of hLEF-1, and mutation of these sites reduced binding to b-catenin in vitro and transactivation in vivo. Remarkably, treatment of cells with TBB, a pharmaceutical inhibitor of CK2, blocked the recruitment and cycling of b-catenin and TLE1 at Wnt target genes in vivo. Taken together, these data indicate that CK2 is required for the assembly and cycling of Wnt-enhancer complexes in vivo.
Results and Discussion
Wnt Coregulators Cycle at Target Genes CK2 associates tightly with nuclear b-catenin and the Wnt transducer, Dishevelled, in Wnt-signaling cells [5, 6] and is required for the expression of Wnt target genes [2] [3] [4] [5] [6] [7] . For determining whether CK2 is recruited with b-catenin to Wnt-induced genes, chromatin immunoprecipitation (ChIP) experiments were used to analyze the endogenous c-Myc and CycD1 genes in synchronized myoblast C2C12 cells treated either with lithium, a GSK3b inhibitor that stabilizes b-catenin, or with Wnt3A-conditioned medium (WCM). Native hLEF-1 bound constitutively to the c-Myc ( Figure 1A ) and CycD1 ( Figure 1B ) genes in C2C12 cells. By contrast, b-catenin appeared at each gene 15-30 min after induction by lithium and oscillated on and off the DNA at repeating 75 min intervals. CK2 was also recruited to these Wnt enhancers and cycled together with b-catenin and other coactivators, including TIP60 and the FACT/SSRP1 elongation factor. No binding of LEF-1 or b-catenin was observed at distal (5 kB) upstream sites (data not shown). Negative-acting Wnt regulators, including the TLE1 corepressor, Mi-2, a subunit of the Mi-2/NURD complex [8] , HDAC1, and GSK3b, were also present at the DNA, but cycled in an alternating manner with b-catenin. Thus GSK3b, which has recently been proposed to repress nuclear-receptor genes [9] , may also function in the nucleus as a transcriptional repressor of Wnt genes.
The observation that b-catenin and CK2 alternate with TLE1 for binding to the CycD1 gene was confirmed by real-time PCR ChIP ( Figure 1C ) and indicates that LEF-1 cannot bind simultaneously to b-catenin and TLE1 in vivo, consistent with previous biochemical studies [10] . A sequential ChIP (reChIP) analysis ( Figure 1D ) revealed that CK2 is present in chromatin complexes isolated with b-catenin antibodies and confirms that these proteins can bind simultaneously to Wnt-responsive genes. Importantly, endogenous b-catenin and CK2 cycled with similar kinetics in cells treated with Wnt3A-conditioned medium (WCM) ( Figure 1E ), concomitant with induction of CycD1 mRNA in these cells ( Figure S1 in the Supplemental Data available online). Importantly, siRNA-mediated depletion of endogenous CK2 significantly impaired b-catenin transactivation of the TOP-FLASH reporter gene in 293 cells, as well as endogenous c-Myc transcription in SW480 cells where Wnt signaling is constitutively active ( Figure 1F ).
CK2 Phosphoryation of LEF-1 Enhances
Binding to Beta-Catenin To test whether CK2 affects transcription directly, we used an in vitro system in which a LEF-1 promoter template (pBRE) was assembled into nucleosomes by incubation with a crude Drosophila embryo S190 chromatin-assembly extract and purified core histones, in the presence or absence of b-catenin and LEF-1 [11] . Interestingly, CK2 enhanced b-catenin:LEF-1 transcription in this system ( Figure 2A , top panel, compare lanes 9 and 10), and this effect was blocked by the pharmaceutical CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB; lane 11). As noted previously [11] , b-catenin strongly enhances binding of LEF-1 to chromatin templates ( Figure 2A , bottom panel, compare lanes 6 and 9), and CK2 enhanced this effect ( Figure 2A , bottom panel, compare lanes 9 and 10; see also Figure 3 ). By contrast, CK2 had no effect on Notch-enhancer-dependent transcription in vitro (data not shown).
In vitro kinase assays indicated that CK2 phosphorylates full-length His-LEF-1 and His-LEF-1DAD, a minimal form of LEF-1 that supports b-catenin activation, but did not phosphorylate DNß-catenin ( Figure S2A ). Human TCF4 is phosphorylated by CK2 at N-terminal residues S58, S59, and S60, which lowers its affinity for plakoglobin (g-catenin) [12] . Although only one of these residues (corresponding to S67) is conserved in human LEF-1, protein analysis of CK2-phosphorylated His-LEF-1DAD by MALDI-TOF mass spectrometry revealed mono-, di-, and tri-phosphorylation of an N-terminal peptide *Correspondence: jones@salk.edu (aa 37-74, Figure 2B ), which includes S67 as well as two series (S42 and S61) that lie within an acidic environment typical of CK2 sites. In vitro kinase assays with mutant His-LEF-1DAD proteins containing either single (S42A, S61A) or double (S42A:S61A) substitutions indicate that both S42 and S61 are key CK2 phosphorylation sites in vitro ( Figure 2C) .
The observation that CK2 phosphorylates at least two residues (S42 and S61) within the LEF-1-b-catenin interaction domain led us to examine whether it influences binding to b-catenin. First, purified GST-b-catenin was coupled to glutathione-S-agarose beads and incubated with purified untreated or CK2-phosphorylated wild-type or mutant S42A:S61A His-LEF-1DAD proteins in GST pull-down experiments. As shown in Figure 3A , CK2 strongly enhanced the binding of b-catenin to wild-type (compare lanes 5 and 6), but not mutant S42A:S61A (compare lanes 3 and 4), His-LEF-1DAD proteins. CK2 also facilitated binding of full-length His-LEF-1 to GST-b-catenin ( Figure 3B, compare lanes  3 and 4) . A triple-point mutation affecting S42, S61, and S67 was as defective as the S42A:S61A mutant in its ability to respond to CK2 (Figure S2C ), whereas a single-point mutation affecting S42, a double mutation affecting S61 and S67, and other mutations retained the ability to be activated by CK2 in vitro ( Figures S2B  and S2C ). Thus CK2 phosphorylates LEF-1 at Ser-42 and Ser-61 to increase its affinity for b-catenin and chromatin templates in vitro.
Interestingly, b-catenin and the Gro/TLE1 corepressor compete for partially overlapping interaction sites within the central and high-mobility group (HMG) domains of LEF-1 [10] . Because this region contains multiple potential CK2 phosphorylation sites, we tested whether CK2 might affect binding of LEF-1 to Gro/TLE1. FLAG-tagged Drosophila Groucho protein, purified from Drosophila S2 cells [13] , was coupled to M2 FLAG-agarose beads and used in pull-down assays with the recombinant full-length His-LEF-1 protein. In these experiments, His-LEF-1 bound avidly to either unphosphorylated or CK2-phosphorylated FLAG-Gro beads ( Figure 3C , compare lanes 3 and 4 with lanes 5 and 7). By contrast, CK2 phosphorylation of LEF-1 strongly blocked binding to both unphosphorylated and CK2-phosphorylated FLAG-Gro proteins (compare lane 5 with 6 and lane 7 with 8, respectively). Both wild-type and S42A:S61A LEF-1DAD proteins bound only weakly to Groucho; however, this interaction was nevertheless inhibited by CK2 ( Figure S3 ), indicating that CK2 phosphorylates the TLE1 binding region of LEF-1DAD. Importantly, CK2 failed to stimulate transcription ( Figure 3D , top panel, compare lanes 3 and 4) or chromatin binding ( Figure 3D , bottom panel, compare lanes 3 and 4) of the mutant S42A:S61A His-LEF-1DAD protein in vitro.
LEF-1 N-Terminal Residues S42 and S61 Facilitate Transactivation In Vivo
For determining whether LEF-1 activity requires S42 and S61, Raji B cells were cotransfected with the TOPFLASH reporter, an activated b-catenin (S33Y), and FLAGtagged wild-type or S42A:S61A mutant LEF-1 constructs, and TOPFLASH reporter-gene activity was monitored relative to a TK-Renilla luciferase control plasmid. As shown in Figure 3E , b-catenin activity was significantly higher when coexpressed with wild-type LEF-1 than with the S42A:S61A mutant LEF-1 protein. Immunoblot analysis confirmed that the wild-type and S42A: S61A mutant LEF-1 proteins were equivalently expressed in the cells, indicating that the predominant N-terminal CK2 phosphorylation sites in LEF-1 are required for transactivation in vivo and in vitro.
CK2 is Required for Recruitment and Cycling of Wnt Coregulators at Target Genes
These data lead us to consider whether CK2 is required for targeting of b-catenin to Wnt target genes in vivo. Moreover, CK2 phosphorylation of TLE1 is required for its repressive activity and association with chromatin [14, 15] . Consequently, we reasoned that CK2 might regulate the binding of both b-catenin and TLE1 to Wnt target genes. To examine this possibility, we carried out ChIP analyses of the CycD1 gene in cells treated with the CK2 inhibitor, TBB, or control dimethyl sulfoxide (DMSO), for 1 hr prior to lithium induction of b-catenin. As shown in Figure 4A , recruitment of b-catenin to the CycD1 gene was dramatically impaired in cells treated with TBB. Similarly, the level of TLE1 at the CycD1 promoter before and after lithium induction was greatly reduced in the presence of TBB ( Figure 4B ). By contrast, TBB had no effect on binding of LEF-1 (Figure 4C) . Induction of CycD1 transcription by lithium was strongly blocked by TBB (Figure 4D ), which did not alter b-catenin or TLE1 levels in the nucleus ( Figure 4E) . A more extensive ChIP analysis revealed that TBB also blocks the cycling of b-catenin at the CycD1 gene ( Figure 4F ), indicating that CK2 is required for assembly and turnover of Wnt-enhancer complexes in vivo.
The finding that CK2 phosphorylates LEF-1 and enhances binding to b-catenin, while blocking binding to TLE1, indicated that it might regulate the assembly of active Wnt enhancers. In this respect, CK2 would function oppositely to CK1, which promotes binding of b-catenin to the APC tumor suppressor, disfavors binding to LEF-1/TCF proteins [16] [17] [18] , and thereby inhibiting Wnt signaling. Thus CK1 and CK2 may control, in opposite ways, the switching of b-catenin and Gro/TLE1 on the LEF-1/TCF platform. LEF-1 residues S42, S61, and S67 are highly conserved, and TCF proteins contain multiple serine and acidic residues in the vicinity of this region, suggesting that activation by CK2 may be conserved among LEF/TCF family members. Interestingly, X-ray crystallography studies indicate that the interaction of b-catenin with E-cadherin, which closely resembles its interaction with TCF4, is similarly enhanced by CK2 phosphorylation [19] . Remarkably, this region of LEF-1 is frequently mutated in human sebaceous-gland tumors [20] , which express a mutant LEF-1(E45K:S61P) protein that is unable to interact with b-catenin. Our findings suggest that the reduced affinity of the mutant LEF-1 (E45K:S61P) protein for b-catenin may arise, in part, from its inability to be phosphorylated by CK2.
It is notable that b-catenin and associated coactivators, including CK2 and FACT, are recruited in a cyclic manner to Wnt-responsive genes. In yeast, CK2 associates with Polymerase-associated Factor 1 (Paf1) and FACT complexes [21] . The observation that b-catenin associates with the Paf1 subunit, Parafibromin [22] , and with Trithorax-related MLL1/2 complexes, to promote histone H3K4 trimethylation in vivo [23] suggests that CK2 might also stimulate transcription elongation at Wnt genes. Moreover, the ability of the wild-type APC tumor suppressor, but not cancer-associated APC mutant proteins, to bind and inhibit CK2 [24] suggests an additional mechanism by which APC may counteract b-catenin transactivation in vivo. It is interesting to speculate that the repetitive cycling of Wnt coregulator complexes might contribute to the oscillating pattern of Wnt gene transcription that is observed during somitogenesis, where Wnt and Notch target genes are under the control of the vertebrate segmentation clock [25] . We note that CK2, CK1, and GSK3b also control circadian gene transcription and that inhibition of CK2 abolishes transcript cycling from these genes in vivo [26] . Thus further studies are needed to assess whether cyclic coregulator recruitment may regulate cyclic transcription, as well as crosstalk among these diverse signaling pathways. 
